ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000192.1|Aclacinomycin_1 # 3 # 668 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.754	BGC0000192.1|Aclacinomycin_1 	3	668	-	Loose	1200	24.6386	arnA	35.71	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGGCGGCCCTGAGCGGGGGCCGGCCGCCGGCCGCGGGATCGCGGATCGCGGTGCTCGGGGCCACCGGCTGTGTCGGACGCTGTGTGAGTGCCGCTCTGGCGCGCGAGGGGCACGAGGTGCTCGCCGTGGCCCGGCGCGGCGGGCCCGCGGTGGCGGATTACCTCTTCGCCGGCCTGGACGTGGCGGCGGTCCCCCCTGCCGAGCTGGCGCGGCTGCTCACCGGGCACCGGGTGCGCGCCGTGGTCAACGTGACGGGCGGCTGGGGCACGACCGAGGAGGAGATGCGGTACGCGCACATCACCCTGGTCGACCGGCTGCTGCGGGCCCTGACACTGATGGACGACCGGCCGCGCCTGGTCCATGTGGGTTCCATCCACGAGTACGGGCCGGTGCCCGAGCCCCTCTCCATCGGCGAGGATCTTCCACCCCGGCCGGCGACGATGTACGCCAGGACCAAGCTGGCCGGCTCCGAGCTGGTGCTCGACGCGGCCAGCACCGGCCGGGTGGACGCCCTGGTGCTGCGCGCGGTGAACGTGTGCGGTCCCCGCACCACCCGGGCCAGTTTCCTCGGGGCGGTCGCCGGCATGCTGCGGGCCGCCGACGCGGCGAACCCGGTGACGCTGCGTGTCGCGGACGCGCGGCGGGACTTCGTCGATGTGCGTGAT	MAALSGGRPPAAGSRIAVLGATGCVGRCVSAALAREGHEVLAVARRGGPAVADYLFAGLDVAAVPPAELARLLTGHRVRAVVNVTGGWGTTEEEMRYAHITLVDRLLRALTLMDDRPRLVHVGSIHEYGPVPEPLSIGEDLPPRPATMYARTKLAGSELVLDAASTGRVDALVLRAVNVCGPRTTRASFLGAVAGMLRAADAANPVTLRVADARRDFVDVRD	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	33.53	gnl|BL_ORD_ID|1513|hsp_num:0	1643			939	1023	polymyxin B
BGC0000192.1|Aclacinomycin_2 # 656 # 1273 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.706	BGC0000192.1|Aclacinomycin_2 	656	1273	-	Loose	560	26.5646	OXA-269	25.0	3001725	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGATTCCGCCGTGCAGTTCCGCGAACTCGCCGTCTCCGGCGCGTTCGTCTTCACTCCGCCCGTCTTCGAGGACGACCGCGGTCTGTTCACCTCGCCGTTCCAGGAACCTGCCTTCGTGGCGGCACTGGGCCACCCCCTGTTCCCGGTCGCGCAGTCCAACCACAGCAGGTCGCGGCGCGGCACCGTACGGGGCATCCACTACACGGTCACCCCGCCGGGCGTGGCGAAGTACGTGTACTGCGCCCGGGGCCGCGCCATCGACATCGTGGTCGACATCCGCGTCGGCTCGCCCACCTACGGCCGCTGGGACTCCTCGGTGCTCGACCCGGAGGGGTTTCGCGCCATGTACTTCCCGGTCGGCGTCGGGCACGCCTTCGTCGCCCTGGAGGACGACACGGTGATGTCGTACATGCTCTCGGGAAGCTACGAGGCGCAGCACGAGATGTCCCTCTCCCCGCTCGACCCCGCGCTCGGCCTGCCGATCCCCCAGGACGTGGCACCCCTGCTGTCCGCGCGGGACACGGCCGCGCCCCTGCTCGAGCAGGTGCGGGCGGAGGGCGGCCTGCCGGAGTACGACAAGTGCCGTCGGATCGAGGCCGCACTGTGGCGGCCCTGA	MDSAVQFRELAVSGAFVFTPPVFEDDRGLFTSPFQEPAFVAALGHPLFPVAQSNHSRSRRGTVRGIHYTVTPPGVAKYVYCARGRAIDIVVDIRVGSPTYGRWDSSVLDPEGFRAMYFPVGVGHAFVALEDDTVMSYMLSGSYEAQHEMSLSPLDPALGLPIPQDVAPLLSARDTAAPLLEQVRAEGGLPEYDKCRRIEAALWRP	MYKKVLIVATTTLFLSACSSKTVKQHQIHSISANQNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKILNALIGLEHHKVTTTEVFKWDGQKRLFPDWEKDMTLGDAMQASAIPVYQKLARRIGLDLMSKEVKRVGFGNADIGSRVDNFWLVGPLKITPLQEAEFAYELAHKTLPFSKNVQEQVQSLVFIEEKNGRKIYAKSGWALDIDPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSIIRKEITYKGLEQLGIL	75.09	gnl|BL_ORD_ID|2496|hsp_num:0	3436			507	717	cloxacillin; oxacillin; cefalotin
BGC0000192.1|Aclacinomycin_3 # 1274 # 2596 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.691	BGC0000192.1|Aclacinomycin_3 	1274	2596	-	Loose	700	58.5362	oleI	31.71	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAAGGTCCTGTTCACCACGTTCGCCGCGAAGTCCCATATGCATGCCCAGGTTCCGCTGGCCTGGGCCCTCCAGACCGCGGGCCACGAGGTCCGTATCGCCAGCCAGCCGGACCTGGCGGAGGACATCACCCGTACCGGACTGACCGCCGTGTGTGTCGGTGAGCCGCTGCTCCTGGAGGAGCAGATGCAGCGGGTCAACGAGGGCCTGGGCGACGACGCCGAGATCATGGAGAGCCAGGCGGAAGCCGGGATGGACATGACGGAGACCCGTCCCGAGATGCTGACCTGGGACCACGTCCTCGGTGTGTTCACCTCGATGACGGCGATGGCCTTCCAGAACTCCTGCCCTGAGCGCATGATCGACGACGTGGTCGCGTTCGCCCGCGAGTGGCAGCCCGACCTGATCGTCTGGGACACGCTGTCCTTCGCGGGGCCGGTGGCCGCGCAGGTCACCGGCGCCGCCCACGCCCGGCTGCTGTTCGGCCTCGATCTGCTGGGGCGGATGCGGGAGACCTTCCTCGACCTTCAGGAGGAGCGGCTGCCCGAGCAGCGGGACGACCCGCTGCGCGAGTGGCTGACCTGGACGCTCGGCCGCTACGGCGCCGAGTTCGAGGAGGAGGTGGCGGTCGGTCAGTGGACCGTCGACCCGGTGCCGCCGTCGATGCGGTTCCCGGTGAAGCAGCCGTTCGTGCCACTGCGGTACATCCCCTACAACGGGCAGGCCGTCATCCCGGACTGGCTGCACGAGCCGCCGAAGAAGCGCCGCGTCTGTCTGACGCTGGGGGTGGCCCACCGCGAGGTGCTGGACGGCGACCGCGCCTCGATCGGCGAACTCGTCGAGGCGCTCGCGGAACTGGACGTCGAGGTGGTCGCGACGCTCAACGAGAAGCAGCTCGCCGGGATGGAACTGCCGGACAACGTCAGGGCCGTCGACTTCGTCCCGCTCAACGCGCTGCTGCCGACCTGCTCCGCGGTCATCCACCACGGTGGCTCCGGCACCTTCCAGACGGCGCTGGCGCATGGTGTCCCGCAGCTCATCGTGCCCGACATGGTCTGGGACACGATCCACAAGGCGAAGCAGCTCGAGCGGTTCGGGGCGGGGCTCTACCTGCACGACGTCGACAACTACACCGCTCAGGACCTGCGCGACCACCTGCTGCGGCTGCTGGAGGAGCCGTCGTTCGCAGAGAACTGCGCGCGTATCCGCCGGGAGATGGTGGGCACGCCGAGCCCCAACGACATCGTCCCGCTGCTGGAGAAGCTCACCGCGGAACACCGCCGTGACCGAGGTGCCCGTGGCACCGTCCGAGGGGAGCAGTAG	MKVLFTTFAAKSHMHAQVPLAWALQTAGHEVRIASQPDLAEDITRTGLTAVCVGEPLLLEEQMQRVNEGLGDDAEIMESQAEAGMDMTETRPEMLTWDHVLGVFTSMTAMAFQNSCPERMIDDVVAFAREWQPDLIVWDTLSFAGPVAAQVTGAAHARLLFGLDLLGRMRETFLDLQEERLPEQRDDPLREWLTWTLGRYGAEFEEEVAVGQWTVDPVPPSMRFPVKQPFVPLRYIPYNGQAVIPDWLHEPPKKRRVCLTLGVAHREVLDGDRASIGELVEALAELDVEVVATLNEKQLAGMELPDNVRAVDFVPLNALLPTCSAVIHHGGSGTFQTALAHGVPQLIVPDMVWDTIHKAKQLERFGAGLYLHDVDNYTAQDLRDHLLRLLEEPSFAENCARIRREMVGTPSPNDIVPLLEKLTAEHRRDRGARGTVRGEQ	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	103.77	gnl|BL_ORD_ID|1684|hsp_num:0	1824			903	1266	oleandomycin
BGC0000192.1|Aclacinomycin_4 # 2682 # 4034 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.735	BGC0000192.1|Aclacinomycin_4 	2682	4034	-	Loose	1800	27.7202	MexD	27.2	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGCACGAGGTGCACACGACCGAACACACGATCACCGTGGCCGCCGCCCCGGAGGCCGTCTTCGGCCTGGTGGAGCGGGCGGAGGACTGGCCGCACGTCTTTCCGCCGAGCCTGCACGTGGAGTATCTGGAGCGGTCGGGCGAGGAGGAGCGGCTGCGCATCTGGGCCACCGCCAACGGCGAGGTCAAGTCCTGGACCTCACGGCGCACCCTGGACCGCGCGGGACTGCGGATCCGGTTCCGCCAGGAGGTCTCCCAGGATCCCGTAGCCGCGATGGGCGGGGAGTGGATCGTCGAGGCGCTCCCCGGCGGCGGCAGCCGGGTCCGGCTGCTGCACGACTTCCGGGCCGTCGACGACCTGGAACGCAACGTCAGCTGGATCCTGGAGGCGATCGAGCGCAACAGCGGGGCCGAGCTGGCCGCGCTGGAGTCCGCCGCGCTGCGCACCGGCACCGACGAGGCGCCCTACACCTTCGAGGACTCGGTGCGCATCGACGCCCCGGCCCAGGACGTGCGGGACTTCCTGCACGACGCGGGGCAGTGGCAGGAACGGCTGCCGCACGTCGCCCGGGTGCTGCTGAAGGAGGACACGCCCGACGTCCAGCACCTGGAGATGGACACCCGCACCCCCGACGGTTCGACGCACACCACGGCTTCGGTGCGGATCTGCCTGCCCGACGGGCGGATCACGTACAAGCAGCTGCAGACGCCGGCCCTGATGTCCGTGCACACCGGGGAGTGGTCGGTACGGGAGATCCCGTCCGGCTGCGTGGCCGTCTCCCGGCACACCGTGGTCGTCAACGCGGCGGCCGTCACCAAGGTCCTCGGTGCCTCCGCGACGACCGCCGACGCCCGCACCTTCATCCGGGACGCGCTCGGCGGCAACAGCACGATCACCATGCGGCACGCCAAGGAGTACGCGCAGCGGCGGGCCGCGACGGAGCCGGTGCCGCCGGCCGAGTACGCCTCGGTCCAGCGGTTCTACGCCCGTCAGATGCGGCTCCTCGACGAGGGCGAGGGGGATGCCTGGGCGGACACCTTCACCGAGGACGGGACCTTCGACCAGAGCTCGTTCGCCGAGCCGCTGCGCGGCCGGGCGGCGATCGCGGCGGCGGTGCGCGGCCGGCCCGCGGCGCCCGCCGGCACGGTGCGCCGGCACTGGCTGGGCCTGCCGGCCGCCTGGCGGTTCCCGGACGGTTCGGTGCGCACGGCCTACGACGCCCTGGTCGTCTCGACCGAGGCGGGCGCCGCTCCGGTGATCCGGCTGAGCACCTCGTGCCAGGACGTCCTCGTCGCCGACGGGGACGGCTGGCTGGTGAGCCACCGCTACGTCGGCCACGACGGGCAGTGA	MAHEVHTTEHTITVAAAPEAVFGLVERAEDWPHVFPPSLHVEYLERSGEEERLRIWATANGEVKSWTSRRTLDRAGLRIRFRQEVSQDPVAAMGGEWIVEALPGGGSRVRLLHDFRAVDDLERNVSWILEAIERNSGAELAALESAALRTGTDEAPYTFEDSVRIDAPAQDVRDFLHDAGQWQERLPHVARVLLKEDTPDVQHLEMDTRTPDGSTHTTASVRICLPDGRITYKQLQTPALMSVHTGEWSVREIPSGCVAVSRHTVVVNAAAVTKVLGASATTADARTFIRDALGGNSTITMRHAKEYAQRRAATEPVPPAEYASVQRFYARQMRLLDEGEGDAWADTFTEDGTFDQSSFAEPLRGRAAIAAAVRGRPAAPAGTVRRHWLGLPAAWRFPDGSVRTAYDALVVSTEAGAAPVIRLSTSCQDVLVADGDGWLVSHRYVGHDGQ	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	43.14	gnl|BL_ORD_ID|1485|hsp_num:0	1523			33	360	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000192.1|Aclacinomycin_5 # 4082 # 4867 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0000192.1|Aclacinomycin_5 	4082	4867	-	Loose	750	28.4906	tet(X)	36.59	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCCGCCTGCATCAGAACGCGTCGCCATCGTCACGGGTGCCACCAGCGGCATCGGTCTCGCCGTGGCCAGGAGCCTGGCCGAAGGCGGTGCGCGGGTCTTCATCTGCGCCCGCGACGGCGACCGGGTCGCCCACACCGTCAAGGAGTTGCGCGAGGCGGGCCACGACGTCGACGGCGCCTCCTGCGACGTACGCGACACCGCGCGGGTACGCGCCTTCGTCCAGGAGGCCAGGGACCGGTTCGGGCCCGTCGACGCCCTGGTGAACAACGCCGGCCGCAGCGGCGGCGGGCACACCGCGCAGATTGCCGACGAGTTGTGGCTCGACGTGATCGAGACCAACCTCAACAGCGTCTTCCGGATGACCCGCGAGGTGCTGACGACCGGCGGGATGCTGGAGCGCGGCGCCGGCCGGATCGTCAACATCGCCTCGACGGGCGGCAAGCAGGGCGTGGCCCTGGGGGCGCCGTACTCGGCGTCGAAGCACGGCGTGGTCGGCTTCACCAAGGCCCTGGGCCTCGAGCTGGCGAAGACGGGCATCACCGTCAACGCGGTCTGCCCGGGTTACGTCGAGACACCGATGGCCGAGCGGGTGCGCCAGGGATACGCCGGCGCCTGGGACATCACCGAGGACGAGGTGCTGGAGAGGTTCGAGGCGAAGATCCCCCTCGGCCGCTACTCCACGCCGGACGAGGTCGCCGGACTCGTCGGCTACCTGCTCTCCTCGACGGCCGCGTCGATCACCGCCCAGGCGATGAACGTCTGCGGCGGGCTCGGCAACTACTGA	MPPASERVAIVTGATSGIGLAVARSLAEGGARVFICARDGDRVAHTVKELREAGHDVDGASCDVRDTARVRAFVQEARDRFGPVDALVNNAGRSGGGHTAQIADELWLDVIETNLNSVFRMTREVLTTGGMLERGAGRIVNIASTGGKQGVALGAPYSASKHGVVGFTKALGLELAKTGITVNAVCPGYVETPMAERVRQGYAGAWDITEDEVLERFEAKIPLGRYSTPDEVAGLVGYLLSSTAASITAQAMNVCGGLGNY	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	67.27	gnl|BL_ORD_ID|763|hsp_num:0	776			42	159	tigecycline; tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000192.1|Aclacinomycin_7 # 5444 # 6715 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.715	BGC0000192.1|Aclacinomycin_7 	5444	6715	+	Loose	750	181.8	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.58	3003463	protein variant model	R121K, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACGGCCCGCCGGGTGGTGATCACCGGCCTGGGAGTGATCGCCCCGGGTGGCATCGGCACCAAGGCGTTCTGGGAACGCGTCGTCTCCGGCGTCTCCGCGACCAGGACCATCACGGCCTTCGACGCGTCCGGGTTCCGCTCCCGGATGGCCGCGGAGTGCGACTTCGACGGCGTCCGCTCGGGCCTGACCGTCCGTGACACCGCACGGCTGGACCGTGCCACCCAGTTCGCGGTGGTCGCCGCGCGCGAGGCGCTCGCCGACAGCGGCATCGAGATCGACGAGAGGAACGCCCACCGCACCGGGGTCAGCCTCGGCTCCGCCGTGGGGTGCACCCAGAAGCTCGAGGAGGAGTACGTCGCGCGCAGTGACGGCGGGCAGCGGTGGCTGGTCGATCACGCCGCCGGCACACCGTACCTGTACGACTACTTCGTGCCGAGTTCGATGGCGGCCGAAGTGGCGTGGGAGGCCGGCGCCGAGGGCCCCGCCGCGCTCGTCTCGGCGGGCTGCACCTCCGGTCTCGACTCCCTCGGGCACGCGCTCGACCTCATCAGGGAGGGCACCGTCGACATCATGATCGCCGGTGGCAGCGACGCGCCCATCGCACCCATCACCGTGGCCTGTTTCGACGCCATCAAGGCGACCTCGCCGCGCAACGACACCCCGGAGCACGCCTCGCGGCCCTTCGACAGGACCCGCAGCGGCTTCGTGCTCGGCGAGGGTGCGGCCGTACTCGTCCTGGAGGAGCGGGAGTCCGCCCTGCGGCGCGGAGCACAGATCTACGCCGAGATCGCGGGCTACGCCGGGCGTGGCAACGCCCACCACATGACCGGACTGCGCCCCGACGGACTGGAGATGTCCGCCGCCATCACCGGCGCCCTCGACGACGCCCGCATCGACCGCGAAGCCGTCGGTTACGTCAACGCGCACGGTACGGCCACCCGGCAGAACGACATCCACGAGACGGCCGCGATCAAGCACAGCCTGGGCGAGCACGCCCACCGGGTCCCGGTCAGCTCCATCAAGGCGGTCATCGGTCACTCGCTCGGCGCCGTCGGCTCCATCGAGGCCGTCGCCTCCGCCCTGGTGATCCGGCACGGAGTGGTGCCGCCCACGGCGGGACTGCACGAGCCCGATCCCCAGCTCGACCTCGACTACGTTCCGCTGACCGCGCGCGATCAGGCCACCGACACCGTGCTGACGGTGGGCAGCGGATTCGGCGGATTCCAGAGCGCCATGGTGCTCACCAGCGCCGAAGGGAGCCGCTCATGA	MTARRVVITGLGVIAPGGIGTKAFWERVVSGVSATRTITAFDASGFRSRMAAECDFDGVRSGLTVRDTARLDRATQFAVVAAREALADSGIEIDERNAHRTGVSLGSAVGCTQKLEEEYVARSDGGQRWLVDHAAGTPYLYDYFVPSSMAAEVAWEAGAEGPAALVSAGCTSGLDSLGHALDLIREGTVDIMIAGGSDAPIAPITVACFDAIKATSPRNDTPEHASRPFDRTRSGFVLGEGAAVLVLEERESALRRGAQIYAEIAGYAGRGNAHHMTGLRPDGLEMSAAITGALDDARIDREAVGYVNAHGTATRQNDIHETAAIKHSLGEHAHRVPVSSIKAVIGHSLGAVGSIEAVASALVIRHGVVPPTAGLHEPDPQLDLDYVPLTARDQATDTVLTVGSGFGGFQSAMVLTSAEGSRS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.68	gnl|BL_ORD_ID|1968|hsp_num:0	1943			303	1239	isoniazid
BGC0000192.1|Aclacinomycin_8 # 6712 # 7935 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0000192.1|Aclacinomycin_8 	6712	7935	+	Loose	700	26.5646	gimA	30.0	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	ATGAGTGCCGCGACCGTGGTCACCGGAATCGGTGTGCTCGCGCCCAACGGGATCGGGGCGGAGGAGTTCTGGGCGGCCACCCTGCGCGCCGAGAGCGGCATCGGCCGCATCACCCGCTTCGAGCCCGCCTCGTATCCCTCCCGGCTGGCCGGCGAGGTCACGGGGTTCTCGGCACGGGACCACATACCGAGCCGGCTCGTCCCGCAGACCGACCGCACCACGCAGTTCGCCCTGACGGGCTCCGAGTGGGCACTGCGGGACTCCGGACTGTCCGCCGACAGCCTGCCGGCGGACGAGCGCGGGGTGGTCACCGCCAGCGCCTCCGGCGGGTTCGAGTTCGGCCAGCGCGAACTGGGCCATCTGTGGGGCAAGGACCCCCGGCACGTCAGCGCGTACATGTCCTTCGCCTGGTTCTACGCCGTCAACTCCGGTCAGATCTCCATCCGGCACGATCTGCGAGGCCCCACCGGAGTGCTCGTCACCGACCAGGCGGGCGGTCTCGACGCGGTGGCACAGGCCAGGCGCCGGATCCGCAAGGGCACCCCGGTCATGCTGTCCGGCGGCATGGACGCCTCGCTGTGCCCCTACGGGCTCGCGGCCCAGATCTCCGCCGGAATGCTCAGCGAGAGCGACGACCCGGCCCGCGCCTACCGGCCGTTCGACCCGGCGGCCGACGGCCATGTGCCGGGCGAGGGCGGGGCGATCCTGACCCTGGAGGACGGGGAACGGGCGCGGGCGCGCGGGGCACGCAGCCACGGGGAGATCAGCGGGTACGCCGCCACCTTCGACCCCCGTCCCGGCTCGGGCCGGCCCGCCAACCTGGACCGGGCGATCCGGGGCGCGCTGGCCGACGCCGGGCTGACCCCGCGGGACATCGCCTTCGTCCTCGCGGACGGCGCCGGTGAACCGGAACCCGACCGGGCCGAGGCGCGGGCGCTCACCGACGTCTTCGGCCCCCGGGGCGTACCCGTGACGGTCCCCAAGAGCATGACGGGGCGCCTCTACGCGGGTGCCGTCCCGCTCGATCTCGTCACCGCCCTGTTCGCACTGCGCGACGGCGTCGTCCCGCCGACGGTCCACGTCGACGGACCGGACCCCGCCTACGACATCGACCTCGTGACCGGCTCCGCCGGCCCGTCCGCGGAGACGCGGGCGCTGGTCCTGGCCCGGGGACGCGGCGGCTTCAACAGCGCCATGGTCGTACGGCGCCCGTCGGCGGCCTGA	MSAATVVTGIGVLAPNGIGAEEFWAATLRAESGIGRITRFEPASYPSRLAGEVTGFSARDHIPSRLVPQTDRTTQFALTGSEWALRDSGLSADSLPADERGVVTASASGGFEFGQRELGHLWGKDPRHVSAYMSFAWFYAVNSGQISIRHDLRGPTGVLVTDQAGGLDAVAQARRRIRKGTPVMLSGGMDASLCPYGLAAQISAGMLSESDDPARAYRPFDPAADGHVPGEGGAILTLEDGERARARGARSHGEISGYAATFDPRPGSGRPANLDRAIRGALADAGLTPRDIAFVLADGAGEPEPDRAEARALTDVFGPRGVPVTVPKSMTGRLYAGAVPLDLVTALFALRDGVVPPTVHVDGPDPAYDIDLVTGSAGPSAETRALVLARGRGGFNSAMVVRRPSAA	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	97.60	gnl|BL_ORD_ID|1924|hsp_num:0	1994			510	693	tylosin; oleandomycin; chalcomycin; methymycin
BGC0000192.1|Aclacinomycin_9 # 8039 # 8314 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.688	BGC0000192.1|Aclacinomycin_9 	8039	8314	+	Loose	1000	26.9498	Clostridium perfringens mprF	40.0	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGTCCGCTTTCACGGTAGAAGAGCTTTTCCAGATCATGCGCGAGTGCGCGGGCGAGGAGGAGGCCGTCGATCTGGCCGACGCCGCGGAGCAGGAGTTCTCCCTGCTCGGCTACGACTCCCTCGCGCTCATGGAGGCGATCAGCAGGGTGGAGCGGGGTCTCGGCATCGACCTGCCCGAGGAGACGGTGGGCGAGGTGCTGACGCCCGCCGCGTTCGTCGACGTCGTCAACGCCGAACTGGCCCGCAGCGCGCCCGTGGTGGAGGCCGCCGGATGA	MSAFTVEELFQIMRECAGEEEAVDLADAAEQEFSLLGYDSLALMEAISRVERGLGIDLPEETVGEVLTPAAFVDVVNAELARSAPVVEAAG	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	15.99	gnl|BL_ORD_ID|2058|hsp_num:0	2282			1026	1116	defensin
BGC0000192.1|Aclacinomycin_11 # 9414 # 10457 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.776	BGC0000192.1|Aclacinomycin_11 	9414	10457	+	Loose	550	25.409	LRG-1	55.0	3006941	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	LRG beta-lactamase	GTGACCGGCACCGCGGGGGCCCTGCCGGTCGCCCTGCTGCTGCCGGGCCAGGGCTCCCAGCACCGGCGGATGGCCGCGGGGCTCTACGGGCACGAGCCGGTGTTCACCGAGGCCATGGACGAGTTCTTCGACGCGGCCGGCCCCGAGGGCGATCCGCTGCGCGACGACTGGCTGGCCGAACGGCCCGTCACGGACATCGACCACGTCACCCGCTCACAGCCGCTGCTCTTCGCCGTGGACCACGCGCTGGGGCGGCTGGTGCTCGGCCGGGGTGTGCGCCCGGCGGCCCTCCTGGGGCACAGTATCGGGGAGCTGGCGGCGGCCACGCTGGCCGGGGTGTTCGCTCCGCGGGACGCCGCCGGCCTGGTGCTCGACCGGATACGGCGGCTGTCGGCGGCTCCGCCGGGCGGCATGCTCGCGGTGGCCGCGTCCACGGCGGAGGTGGCCCCGTACCTGAGGGGAGACGTCGTGGTCGGCGCGGTCAACGCCCCGCGGCAGACCGTGCTCGCCGGACCCGACGGCCCGCTGGACGAGGTGGACCGTGCCCTGCGGGAGGCCGGGTTCGTCTGCCGCCGGGTGCCGTCGCTGAGCGCCTTCCACAGCCCGGTGCTCGAACCCGCCTGCCGGGGGGCGGCCCCTCTCTTCGCCGCGGCCTGCAAGCATCCGCCGGCCGTGCCGGTCCACTCCGCCTACACCGCCGCCCCGCTGACGGAGTCAGACATCGACGACCCCGCCTTCTGGGCGCGGCAGCCGGTGGCGCCGGTGCTGTTCTGGCCCGCTCTGGAAGGGCTGCTGGCCACCGGCGACCATCTGCTGGTGGAGGTGGGGCCGGGACAAGGGCTGTCCCAGCTGGTCCGCCGTCACCCGGCTGTGCGCCGGGGCGGCAGTGCCGTGGTGTCGCTGCTTCCGGCGCGGCCGGGGCCGCCGGAGGCGGACCGGGCCGCGGTGGCCGCCGCCACGGAGCAGATCACGGCGGCGGGGCGCCAGGCCGCCCCCGCGAGCGCGGACCACGGCCGGCCGTCACGGCAGGCCGCGGCCGGCTGA	MTGTAGALPVALLLPGQGSQHRRMAAGLYGHEPVFTEAMDEFFDAAGPEGDPLRDDWLAERPVTDIDHVTRSQPLLFAVDHALGRLVLGRGVRPAALLGHSIGELAAATLAGVFAPRDAAGLVLDRIRRLSAAPPGGMLAVAASTAEVAPYLRGDVVVGAVNAPRQTVLAGPDGPLDEVDRALREAGFVCRRVPSLSAFHSPVLEPACRGAAPLFAAACKHPPAVPVHSAYTAAPLTESDIDDPAFWARQPVAPVLFWPALEGLLATGDHLLVEVGPGQGLSQLVRRHPAVRRGGSAVVSLLPARPGPPEADRAAVAAATEQITAAGRQAAPASADHGRPSRQAAAG	MNSIFSLSRRKYLLAAAGLTIAALFPPSVVLAEQPATLAAQLSALEASANGRLGVALIDSGSSRQLSYRGEERFAMASTFKALAAAAVLQRSVEQPALLNKRIIYQQSELITYSPVTEKHLQQGMTVAELCAAAVELSDNTAGNILLREIGGPQGITQLARRLGDNQTRLDRREPALNSAIPGDVRDTSTPLAMAGNLNQLALGKALPSAQQQLLIQWLKQSKTGAQSIRAGVPQGWQVGDKTGAGGYGTTNDLAILWPPQGKPLVLAVYFTQHNPQAEARRDVLASATRLVLAAWEKQ	116.05	gnl|BL_ORD_ID|3682|hsp_num:0	4752			426	486	
BGC0000192.1|Aclacinomycin_12 # 10511 # 11371 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.708	BGC0000192.1|Aclacinomycin_12 	10511	11371	-	Loose	500	30.0314	rmtC	27.54	3000861	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGGACACGTCCACCTACAAATCCGAAGTGGCGGCCGCCTTCAACAGCGCCGCGGCGACCTACGACCGGCTCGGCGTGGAATTCTTCACCCCGATGGGCCGGCGTCTGGTGGAACGCGCGGCACCGGCCGCCGGCGCCCGGGTCCTCGACGTCGGCTGCGGGCGGGGCGCGTGCGTCTTCCCGGCTGCCGAACGCGTGGGGCCCGAGGGCCGTGTCGTGGGCATCGACGTCGCCGAGGCGATGATCGAGGAGGCCACGAAGGAGGCGGCGCTGCGCGACGCCGCCATGGTCGAGCTGCGGGTGATGGACGGGGAGCACCCCGACTTCGCGCCGCACTCCTTCGACGTGGTCCTGGGCAGCTACAGCGTCATCTTCCTGCCCGACGCCCCGACGGCGCTGGCCCGTTACGCGCCGCTGCTCTCCCCCGGGGGCCGACTCGCCTTCACCAGCCCGGTGTTCAGCGACGACACCTTCCCCTTCCTGCCCCCGGTGTTCACCGAACTGATCCCGCGCGAGCTGCTGCTCGACCTGCCGCCGCAGTGGCAGCCCGAACAGCTTCAGCAGCGCTTCAACAGCTGGCTCGCGGACCCGCGGGACCTCACCCGCACACTGGAGCGGTGCGGCTTCCAAGAGGTGACGGTCGTCGACGAACCCGTGACTCTGGTGGCCGAATCGGGCCTGGCCTGGGTGGACTGGTCGCACACCCAGGGGATGCGCCTGCTCTGGAACCACCTGGCGCAGGACAAACGTCAGCAGCTGCGGGAGCGGCTGATCACCTCGCTCGACGCGATGCGGGACGGGGACGGCCCGCTCACGATCGACACCCCGGTGCGGTACGTCACCGCGACCGTACGGAACTGA	MDTSTYKSEVAAAFNSAAATYDRLGVEFFTPMGRRLVERAAPAAGARVLDVGCGRGACVFPAAERVGPEGRVVGIDVAEAMIEEATKEAALRDAAMVELRVMDGEHPDFAPHSFDVVLGSYSVIFLPDAPTALARYAPLLSPGGRLAFTSPVFSDDTFPFLPPVFTELIPRELLLDLPPQWQPEQLQQRFNSWLADPRDLTRTLERCGFQEVTVVDEPVTLVAESGLAWVDWSHTQGMRLLWNHLAQDKRQQLRERLITSLDAMRDGDGPLTIDTPVRYVTATVRN	MKTNDNYIEEVTAKVLTSGKYSTLYPPTVRRVTERLFDRYPPKQLEKEVRKKLHQAYGAYIGGIDGKRLEKKIEKIIHEIPNPTTDEATRTEWEKEICLKILNLHTSTNERTVAYDELYQKIFEVTGVPTSITDAGCALNPFSFPFFTEAGMLGQYIGFDLDKGMIEAIEHSLRTLNAPEGIVVKQGDILSDPSGESDLLLMFKLYTLLDRQEEASGLKILQEWKYKNAVISFPIKTISGRDVGMEENYTVKFENDLVGSDLRIMQKLKLGNEMYFIVSRL	101.78	gnl|BL_ORD_ID|1417|hsp_num:0	1540			324	501	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0000192.1|Aclacinomycin_13 # 11570 # 12004 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.653	BGC0000192.1|Aclacinomycin_13 	11570	12004	+	Loose	400	23.8682	ArnT	43.75	3005053	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGAGTGAGCAGATAGCGGCCGTTCGGCGCATGGTCGAGGCGTACAACACCGGAAAAACGGATGATGTGGCCGACTACATCCATCCGGAATACATGAATCCGGGAACCCTGGAATTCACCTCGCTGCGTGGCCCGGAACTCTTCGCGATCAATGTCGCGTGGGTCAAGAAGACGTTCTCCGAGGAGGCGCGGCTGGAAGAGGTCGGCATCGAGGAGCGGGCCGACTGGGTGCGCGCCCGGCTGGTGCTCTACGGCCGGCACGTCGGTGAGATGGTCGGCATGGCGCCGACCGGACGGCTGTTCTCCGGCGAGCAGATCCATCTCCTGCACTTCGTCGACGGGAAGATCCACCACCACCGCGACTGGCCCGACTACCAGGGCACCTACCGCCAGCTCGGCGAGCCGTGGCCGGAGACCGAGCACCGCCGTCCCTGA	MSEQIAAVRRMVEAYNTGKTDDVADYIHPEYMNPGTLEFTSLRGPELFAINVAWVKKTFSEEARLEEVGIEERADWVRARLVLYGRHVGEMVGMAPTGRLFSGEQIHLLHFVDGKIHHHRDWPDYQGTYRQLGEPWPETEHRRP	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	26.13	gnl|BL_ORD_ID|2783|hsp_num:0	3795			1437	1485	colistin A; colistin B
BGC0000192.1|Aclacinomycin_14 # 12036 # 12890 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.730	BGC0000192.1|Aclacinomycin_14 	12036	12890	+	Loose	400	27.7202	vanR gene in vanM cluster	30.0	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGGGGGCGCGATGGAGTTCGGTGTTCTGGGACCGCTGTACGTGCGGGTGAACGGTGCGACCACCGCGCCGAGCGCCCCGAAACTGCGGAACGTGCTGGCGATGCTGCTCGTCCACGCGGGGCAGGTGGTGCCTGTGCCGTCGCTGGTGCGGGACCTGTGGGACGAGGATCCGCCGGTCAGCGGCCTGACCACGCTGCAGACGTACATCCTGAACCTGCGCAAGATGTTCTCCGCGGTCACCGGACTGACCACCGCGGAGGTGGCCCGCGACGTCCTGGTGACCCGTGCGGGCGGATACGCGCTGGCCGCGGAGGCCGGCGTGCTCGACATCCACCGCTACCAGCGCCTCGTGACCTCCGGCCGAGAGGCCCTGGCGCGCGGTGACGACGCGGCCGGGGTTCGGGACCTGAACGAGGCGCTGCTGCTGTGGCGGGGCCCCGCGCTGGCGGACGTACCGGCGGGGCGGGTGCTGGAGAGCAGGCGCCGGCAGCTGGAGGAGTCCCGGCTCGCCGCCTTCGAATACCTGGTCGACGTGGAGCTGCGGCTCGGCATGTACCGCGAGGTGCTCGCCGAGCTGGCCGCCCTCACGGTGGAGAACCCGCTGCACGAGGGGCTGCACGGCCAGTACATGTGGGCCCTGCACCTCAGCGGGCGGCGGGCCCAGGCGTTGCAGGTCTTCCACCGGCTGCGGGGTGCGCTGGTGGCGGGTCTCGGCCTGGAGCCGGGTCCGCAGGTGCAGCGGCTGCACCAGGCGGTGCTGAACGCGGACACCGCCTTCGAACCCCGCTTCACCGTGCGCCGGACCGCGGTCGCCGCGTCGGCCACGGCCTTCGGGGGCGGACGGTCGTACTGA	MGGAMEFGVLGPLYVRVNGATTAPSAPKLRNVLAMLLVHAGQVVPVPSLVRDLWDEDPPVSGLTTLQTYILNLRKMFSAVTGLTTAEVARDVLVTRAGGYALAAEAGVLDIHRYQRLVTSGREALARGDDAAGVRDLNEALLLWRGPALADVPAGRVLESRRRQLEESRLAAFEYLVDVELRLGMYREVLAELAALTVENPLHEGLHGQYMWALHLSGRRAQALQVFHRLRGALVAGLGLEPGPQVQRLHQAVLNADTAFEPRFTVRRTAVAASATAFGGGRSY	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	122.41	gnl|BL_ORD_ID|4735|hsp_num:0	752			477	624	vancomycin; teicoplanin
BGC0000192.1|Aclacinomycin_15 # 12975 # 13445 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.667	BGC0000192.1|Aclacinomycin_15 	12975	13445	+	Loose	750	23.8682	tet(40)	27.27	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGGAGAAGGACCAGTCGCAGCGGACGGAACAGCAGGACGAGGCGCCCCTGGACAGTCCCACGGGGTGGGTGGCGGCGCACATCCGCCGTTACGACCGCAGCGGCGGGAAGGAGGGGCAGAAGTGGTACGGGCTCGACACGCTGCTCCTGACCACCCGCGGCCGGAAATCGGGCCGGCTCCGCCGCACCGCGGTGATCTACGGCCGGGACGGCGGCAACATCATCGTCGTCGGATCGAACGGGGGAAAGCCCGAGCACCCCTTGTGGTACCTCAACCTCGTCGCCTCGCCCGAGGCCCACGTCCAGATCGGTGAGGAACATCTGGATGTGCGGGCGCGCACGGCGACCGCCGAGGAGAAGCCGGATCTCTGGAAGCTGATGACGGGGCTCTTTCCCCAGTACAAGAGTTACCAGAAGAAGACCGACCGGGAAATTCCGGTGGTCATTCTGGAGCCCGTCGAGCAGTGA	MPEKDQSQRTEQQDEAPLDSPTGWVAAHIRRYDRSGGKEGQKWYGLDTLLLTTRGRKSGRLRRTAVIYGRDGGNIIVVGSNGGKPEHPLWYLNLVASPEAHVQIGEEHLDVRARTATAEEKPDLWKLMTGLFPQYKSYQKKTDREIPVVILEPVEQ	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	38.42	gnl|BL_ORD_ID|891|hsp_num:0	945			777	963	tetracycline
BGC0000192.1|Aclacinomycin_16 # 13519 # 15150 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.709	BGC0000192.1|Aclacinomycin_16 	13519	15150	+	Loose	2000	26.5646	adeJ	26.72	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTTGAACGAATTCACGCGCCGCGGATTCCTCGGCACCGCGGCAGCGGTCGGCGGAACCACCGTGGTGACCACGGCCCTGGGCGGAGCCCCGGCCGCCCAGGCGGCCGTCCCGGAAGCGGCGGACGGTGGCGCGTGCGGCGCGCGGACCGCGCTGGTGAAGGTGGACCGGGTGGACCGGCGCTACCAGGACCTGGTCACCAGGGGCTTCAACGGGCGCTTCCGCGGCCGGCCCGACGTCGTGTACGTCGTCCACACCGCGGACCAGGTCGTCGACGCGGTGAACCAGGCCATGGCCGCGGGCCAGCGGATCGCGGTGCGCAGCGGCGGGCACTGCTTCGAGGGCTTCGTGGACGATCCCGCCGTCCGGGCCGTCATCGACATGTCCCAGATGAGGCAGGTCTTCTACGACTCCGGCAAGCGGGCGTTCGCCGTGGAACCCGGCGCCACCCTCGGGGAGACGTACCGGGCCCTGTATCTGGACTGGGGCGTGACCATCCCGGCCGGCGTCTGCCCCCAGGTGGGCGTCGGCGGCCATGTGCTGGGCGGAGGCTACGGTCCGCTGTCCCGCCGGGACGGCGTGGTGGCCGACCATCTGTACGCGGTCGAGGTCGTCGTCGTGGACGCCTCGGGCCGGGCCCGCAAGGTCGTGGCCACGAGCGCCGCGGACGACCCCAACCGAGAGCTGTGGTGGGCCCACACCGGCGGCGGCGGAGGCAACTTCGGGATCGTCACCCGGTACTGGTTCCGCACCCCCGGGGCCACCGGCACCGACCCGTCCCAACTCCTGCCCAAGGCCCCCACGTCCACCCTGCGCCACATCGTGACCTGGGACTGGTCCGCTCTCACCGAGGAGGCGTTCACCCGGATCATCGACAACCACGGGGCCTGGCACCAGAGCAACAGCGCCGCCGGCACCCCGTACGCCAGCATGCACAGCGTCTTCTACCTCAACAGCCGTGCGGCCGGTCAGATCCTGCTGGACATCCAGATCGACGGCGGCCTGGACGGCGCCGAGGCCCTGCTGAACGACTTCGTGGCCGCGGTCAACGAGGGCACCGGCGTCGAGCCCGCCGTGCAGCGGAGCACGGAGCCGTGGCTGCGCGCCACGCTGGCCAACAAGTTCGACACCGGCGGCTTCGACCGGACCAAGTCGAAGGGCGCGTATCTGCGCAAGCCCTGGACCGCCGCCCAGGCCGCCACTCTCTACCGCCATCTGAGCGCCGACTCCCAGGTCTGGGGAGAGGTCTCGCTCTACTCGTACGGAGGCAAGGTCAACTCCGTGCCGGAGACGGCCACGGCCACGGCCCAGCGCGACTCCATCATCAAGGTGTGGATGTCGGCGACCTGGATGGATCCCGCCCACGACGATGCCAACCTCGCCTGGATCCGGGAGATCTACCGCGAGATCTTCGCCACCACCGGCGGCGTTCCGGTGCCCGACGACCGCACGGAGGGCACCTTCATCAACTATCCCGACGTCGACCTGGTCGACGAGCGGTGGAACACCTCGGGAGTCCCCTGGTACACCCTCTACTACAAGGGGAACTACCCGCGCCTGCAGAAGGTCAAGGCGCGCTGGGATCCCCGTGACGTCTTCCGGCACGCGCTGTCCGTGCGGCCGCCCGGCTGA	MLNEFTRRGFLGTAAAVGGTTVVTTALGGAPAAQAAVPEAADGGACGARTALVKVDRVDRRYQDLVTRGFNGRFRGRPDVVYVVHTADQVVDAVNQAMAAGQRIAVRSGGHCFEGFVDDPAVRAVIDMSQMRQVFYDSGKRAFAVEPGATLGETYRALYLDWGVTIPAGVCPQVGVGGHVLGGGYGPLSRRDGVVADHLYAVEVVVVDASGRARKVVATSAADDPNRELWWAHTGGGGGNFGIVTRYWFRTPGATGTDPSQLLPKAPTSTLRHIVTWDWSALTEEAFTRIIDNHGAWHQSNSAAGTPYASMHSVFYLNSRAAGQILLDIQIDGGLDGAEALLNDFVAAVNEGTGVEPAVQRSTEPWLRATLANKFDTGGFDRTKSKGAYLRKPWTAAQAATLYRHLSADSQVWGEVSLYSYGGKVNSVPETATATAQRDSIIKVWMSATWMDPAHDDANLAWIREIYREIFATTGGVPVPDDRTEGTFINYPDVDLVDERWNTSGVPWYTLYYKGNYPRLQKVKARWDPRDVFRHALSVRPPG	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	51.32	gnl|BL_ORD_ID|574|hsp_num:0	630			606	933	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
